FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3216161010> ?p ?o ?g. }

• W3216161010 abstract "Immune-related adverse events (irAEs) can impair the effectiveness and safety of immune checkpoint inhibitors (ICIs) and restrict the clinical applications of ICIs in oncology. The predictive biomarkers of irAE are urgently required for early diagnosis and subsequent management. The exact mechanism underlying irAEs remains to be fully elucidated, and the availability of predictive biomarkers is limited. Herein, we performed data mining by combining pharmacovigilance data and pan-cancer transcriptomic information to illustrate the relationships between alternative splicing characteristics and irAE risk of ICIs. Four distinct classes of splicing characteristics considered were associated with splicing factors, neoantigens, splicing isoforms, and splicing levels. Correlation analysis confirmed that expression levels of splicing factors were predictive of irAE risk. Adding DHX16 expression to the bivariate PD-L1 protein expression-fPD1 model markedly enhanced the prediction for irAE. Furthermore, we identified 668 and 1,131 potential predictors based on the correlation of the incidence of irAEs with splicing frequency and isoform expression, respectively. The functional analysis revealed that alternative splicing might contribute to irAE pathogenesis via coordinating innate and adaptive immunity. Remarkably, autoimmune-related genes and autoantigens were preferentially over-represented in these predictors for irAE, suggesting a close link between autoimmunity and irAE occurrence. In addition, we established a trivariate model composed of CDC42EP3-206, TMEM138-211, and IRX3-202, that could better predict the risk of irAE across various cancer types, indicating a potential application as promising biomarkers for irAE. Our study not only highlights the clinical relevance of alternative splicing for irAE development during checkpoint immunotherapy but also sheds new light on the mechanisms underlying irAEs." @default.
• W3216161010 created "2021-12-06" @default.
• W3216161010 creator A5009065617 @default.
• W3216161010 creator A5070267154 @default.
• W3216161010 creator A5081785928 @default.
• W3216161010 date "2021-11-24" @default.
• W3216161010 modified "2023-09-27" @default.
• W3216161010 title "Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy" @default.
• W3216161010 cites W1749413658 @default.
• W3216161010 cites W1831050183 @default.
• W3216161010 cites W1994196736 @default.
• W3216161010 cites W2011920499 @default.
• W3216161010 cites W2014330392 @default.
• W3216161010 cites W2027847170 @default.
• W3216161010 cites W2035618305 @default.
• W3216161010 cites W2074289946 @default.
• W3216161010 cites W2086445388 @default.
• W3216161010 cites W2094803369 @default.
• W3216161010 cites W2105081948 @default.
• W3216161010 cites W2130410032 @default.
• W3216161010 cites W2157115023 @default.
• W3216161010 cites W2159707944 @default.
• W3216161010 cites W2164917731 @default.
• W3216161010 cites W2166939228 @default.
• W3216161010 cites W2513665253 @default.
• W3216161010 cites W2529299484 @default.
• W3216161010 cites W2537231733 @default.
• W3216161010 cites W2547133566 @default.
• W3216161010 cites W2566319641 @default.
• W3216161010 cites W2611548364 @default.
• W3216161010 cites W2783137027 @default.
• W3216161010 cites W2789502254 @default.
• W3216161010 cites W2795877840 @default.
• W3216161010 cites W2809476308 @default.
• W3216161010 cites W2885227878 @default.
• W3216161010 cites W2891486030 @default.
• W3216161010 cites W2893661369 @default.
• W3216161010 cites W2921387793 @default.
• W3216161010 cites W2969320113 @default.
• W3216161010 cites W2969643975 @default.
• W3216161010 cites W2980830192 @default.
• W3216161010 cites W3010582098 @default.
• W3216161010 cites W3015154527 @default.
• W3216161010 cites W3088384582 @default.
• W3216161010 cites W3090511595 @default.
• W3216161010 cites W3105486497 @default.
• W3216161010 cites W3106005610 @default.
• W3216161010 cites W3124110755 @default.
• W3216161010 cites W3128782849 @default.
• W3216161010 cites W3153806629 @default.
• W3216161010 cites W3173714375 @default.
• W3216161010 cites W3175053183 @default.
• W3216161010 cites W4313365953 @default.
• W3216161010 cites W4375856186 @default.
• W3216161010 doi "https://doi.org/10.3389/fphar.2021.797852" @default.
• W3216161010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34899357" @default.
• W3216161010 hasPublicationYear "2021" @default.
• W3216161010 type Work @default.
• W3216161010 sameAs 3216161010 @default.
• W3216161010 citedByCount "7" @default.
• W3216161010 countsByYear W32161610102022 @default.
• W3216161010 countsByYear W32161610102023 @default.
• W3216161010 crossrefType "journal-article" @default.
• W3216161010 hasAuthorship W3216161010A5009065617 @default.
• W3216161010 hasAuthorship W3216161010A5070267154 @default.
• W3216161010 hasAuthorship W3216161010A5081785928 @default.
• W3216161010 hasBestOaLocation W32161610101 @default.
• W3216161010 hasConcept C104317684 @default.
• W3216161010 hasConcept C121608353 @default.
• W3216161010 hasConcept C126322002 @default.
• W3216161010 hasConcept C150194340 @default.
• W3216161010 hasConcept C162317418 @default.
• W3216161010 hasConcept C194583182 @default.
• W3216161010 hasConcept C197934379 @default.
• W3216161010 hasConcept C203014093 @default.
• W3216161010 hasConcept C2777701055 @default.
• W3216161010 hasConcept C53345823 @default.
• W3216161010 hasConcept C54355233 @default.
• W3216161010 hasConcept C54458228 @default.
• W3216161010 hasConcept C60644358 @default.
• W3216161010 hasConcept C67705224 @default.
• W3216161010 hasConcept C70721500 @default.
• W3216161010 hasConcept C71924100 @default.
• W3216161010 hasConcept C86803240 @default.
• W3216161010 hasConcept C8891405 @default.
• W3216161010 hasConceptScore W3216161010C104317684 @default.
• W3216161010 hasConceptScore W3216161010C121608353 @default.
• W3216161010 hasConceptScore W3216161010C126322002 @default.
• W3216161010 hasConceptScore W3216161010C150194340 @default.
• W3216161010 hasConceptScore W3216161010C162317418 @default.
• W3216161010 hasConceptScore W3216161010C194583182 @default.
• W3216161010 hasConceptScore W3216161010C197934379 @default.
• W3216161010 hasConceptScore W3216161010C203014093 @default.
• W3216161010 hasConceptScore W3216161010C2777701055 @default.
• W3216161010 hasConceptScore W3216161010C53345823 @default.
• W3216161010 hasConceptScore W3216161010C54355233 @default.
• W3216161010 hasConceptScore W3216161010C54458228 @default.
• W3216161010 hasConceptScore W3216161010C60644358 @default.
• W3216161010 hasConceptScore W3216161010C67705224 @default.
• W3216161010 hasConceptScore W3216161010C70721500 @default.

• next